New York Life Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,245
| Closed | -$572K | – | 1338 |
|
|
2023
Q4 | $572K | Sell |
9,245
-235
| -2% | -$14.5K | 0.01% | 784 |
|
|
2023
Q3 | $436K | Sell |
9,480
-1,510
| -14% | -$69.4K | ﹤0.01% | 817 |
|
|
2023
Q2 | $632K | Sell |
10,990
-1,591
| -13% | -$91.4K | 0.01% | 636 |
|
|
2023
Q1 | $472K | Sell |
12,581
-3,180
| -20% | -$119K | 0.01% | 1059 |
|
|
2022
Q4 | $442K | Buy |
15,761
+1,741
| +12% | +$48.8K | 0.01% | 1004 |
|
|
2022
Q3 | $394K | Buy |
14,020
+1,030
| +8% | +$28.9K | ﹤0.01% | 958 |
|
|
2022
Q2 | $452K | Buy |
+12,990
| New | +$452K | 0.01% | 783 |
|